{{Rsnum
|rsid=4754
|Gene=SPP1
|Chromosome=4
|position=87981540
|Orientation=plus
|GMAF=0.3751
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SPP1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 31.0 | 61.9
| HCB | 53.3 | 34.1 | 12.6
| JPT | 35.4 | 51.3 | 13.3
| YRI | 4.1 | 18.4 | 77.6
| ASW | 3.5 | 29.8 | 66.7
| CHB | 53.3 | 34.1 | 12.6
| CHD | 48.6 | 41.1 | 10.3
| GIH | 11.0 | 44.0 | 45.0
| LWK | 3.7 | 33.0 | 63.3
| MEX | 17.2 | 48.3 | 34.5
| MKK | 5.8 | 26.9 | 67.3
| TSI | 8.9 | 55.4 | 35.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=20075512
|Title=Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population
|OA=1
}}

{{PMID|16600026|OA=1
}} Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway.

{{PMID|21810982}} Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.

{{PMID Auto
|PMID=24831687
|Title=Association between Secreted Phosphoprotein-1 (SPP1) Polymorphisms and Low Bone Mineral Density in Women
|OA=1
}}

{{PMID Auto
|PMID=24913806
|Title=Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma
}}

{{PMID Auto
|PMID=25009318
|Title=Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}